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Abstract 
Clinical trial protocols include detailed temporal con-
straints on treatment and associated tasks. Unlike 
health-care guidelines, protocols are highly prescrip-
tive. Therefore, informatics applications that enforce 
such temporal constraints are more directly useful 
with protocols than with guidelines. Although there 
are some temporal knowledge representation efforts 
for health-care guidelines, we find these to be insuffi-
ciently expressive for clinical trial protocols. In this 
paper, we focus on temporal knowledge representa-
tion for clinical trial protocols and the task of patient-
specific scheduling in protocols. We define a tempo-
ral ontology, use it to encode clinical trial protocols, 
and describe a prototype tool to carry out patient-
specific scheduling for the tasks in protocols. We 
predict that an expressive temporal knowledge repre-
sentation can support a number of scheduling and 
management tasks for protocol-based care. 
Motivation 
Clinical trial protocols are the defining documents 
used in medical research. They provide detailed plans 
and temporal constraints that health-care providers 
must follow, so that statistically valid data are col-
lected about the efficacy and safety of a particular 
treatment regimen or new agent. Unfortunately, clini-
cal trial protocols are currently disseminated and 
managed in a paper-based manner, which can lead to 
errors and inefficiencies in interpretation and execu-
tion. Thus, one focus of medical informatics research 
is to automate and make electronic and computational 
the elements of guidelines and protocols.  
However, although good progress has been made in 
the domain of standard knowledge representations for 
guidelines,
1–3 knowledge representation specifically 
for clinical trial protocols remains largely ignored. 
We argue that there are crucial differences between 
health-care guidelines and clinical trial protocols, and 
that there are scheduling applications for protocols 
that require sophisticated knowledge modeling of 
temporal information.  
Protocol scheduling tasks 
When a particular individual enrolls in a protocol, 
care providers need an appropriate schedule to carry 
out the protocol tasks across a set of patient visits. 
One study shows that clinicians have a strong desire 
for help with scheduling and co-ordination of inter-
ventions during maintenance therapy for acute lym-
phoblastic leukemia.
4 During the course of patient 
care, this schedule might need to be adjusted dynami-
cally based on changes in the patient state. Large 
multi-site protocols describe procedures and sched-
ules for patient care in a site-independent manner, 
and this makes them inappropriate for direct use in 
scheduling visits for a particular patient. The paper-
based manual process of generating visit schedules 
for patients tends to be time-consuming and error-
prone. Worse, some protocols may contain either 
ambiguity or inconsistency about their temporal re-
quirements across different sections in the protocol.
5 
Regardless of the source of errors, inappropriate 
schedules can decrease the quality of protocol data, 
lengthen the duration of the study, and hamper effec-
tive patient management.  
By definition, scheduling involves the specification 
and application of temporal information about tasks. 
If we could precisely specify and correctly apply 
temporal information in clinical trial protocols, we 
would have the potential to greatly improve the qual-
ity and cost-effectiveness of protocol-based care. In 
this paper, we describe the temporal knowledge re-
quirements for such a model, and present both a pro-
totype model that conforms to those requirements and 
an example of a scheduler that uses this model.  
Temporal information in protocols 
In Table 1, we provide some examples of protocol 
text that convey temporal information. These exam-
ples are drawn from a review of dozens of phase 2 
and phase 3 protocols that were sponsored either by 
pharmaceutical companies or by cooperative groups 
including the Gynecologic Oncology Group (GOG), 
the Southwest Oncology Group (SWOG), and the 
National Surgical Adjuvant Breast and Bowel Project 
(NSABP).  
As Table 1 shows, temporal constraints in clinical 
trial protocols are expressed at a much finer level of 
detail than is typical for health-care guidelines. Tem-
poral information in guidelines is often vague and 
approximate. In contrast, the temporal constraints in Table 1 are rigid, and allow for little variability—in 
most situations, when protocol constraints are vio-
lated; the corresponding clinical data is invalid for 
use. For these reasons, work in standard knowledge 
representation for health care guidelines (e.g., GLIF)
3 
does not include sufficient detail for automating pro-
tocol scheduling.  
Therefore, we take a broader look at the knowledge-
level requirements of a model for temporal informa-
tion in protocols. We expect that if temporal knowl-
edge is modeled well, then this model could be used 
by a set of different decision-support tools for use in 
the clinical trial protocol lifecycle. Although we are 
especially motivated by the patient scheduling task 
presented above, we try to anticipate the temporal 
modeling needs for other tasks associated with proto-
col-based care and management. 
Protocol requirements for temporal KR  
From a knowledge representation standpoint, it is 
useful to view clinical trial protocols as examples of a 
plan.
6 Viewed in this manner, all of the temporal 
specifications in various sections of the protocol (the 
dosing schedule, the treatment schedule, the study 
calendar, etc.) simply define which activities occur 
when, under what conditions. Based on our review of 
protocols, we identified the following knowledge-
level requirements for a temporal model that is suffi-
ciently expressive to support patient scheduling tasks 
in clinical trial protocols.  
Represent relative time information Temporal in-
formation about clinical data is often naturally ex-
pressed in relative terms.
7 In Table 1, row 5, the 
phrases “day 1” and “day 2” are relative to each cy-
cle’s start time. By using relative time, we can pro-
vide useful context information for clinical data. In 
clinical trial protocols, there is a great deal of tempo-
ral inter-dependence of activities. Absolute time 
stamps do not capture the temporal relationships be-
tween activities, nor are they intuitive for clinical trial 
protocol authors. Ultimately, to produce a patient 
schedule, we need to provide absolute time points. 
However, temporal information in the protocol, is 
best expressed relative to a few critical “anchor 
points”, such as the start of treatment. Given the no-
tion of an “anchored time point”, and a representation 
of relative time, we can compute the actual occur-
rence of an activity once the anchor point has an ab-
solute time stamp for a particular patient. 
Context within protocol  Textual examples that include temporal knowledge 
1. Overall schedule of the study in the 
schema of a protocol 
“External Beam, Whole Pelvis Radiation Therapy, 180 cGy daily 
fraction Monday through Friday x 25 days.” 
2. Time constraints in eligibility criteria  “Measurable Disease: must have measurable tumor by MRI that 
has not received radiation within 6 weeks prior to study entry.” 
3. Dose schedule and duration 
“Concurrent Weekly Cisplatin and Paclitaxel on Mondays Cis-
platin 40mg/m2/week x 6 – (70 mg max) Paclitaxel 30 
mg/m2/week x 6 – (Starting dose) ” 
4. Dose modification schedule (which de-
pends on adverse event monitoring schedule) 
“Administration of AC will be delayed on day 1 if granulocytes < 
1500; resume treatment if granulocytes >= 1500 ”. 
5. Treatment schedule  “Arm 1, dexamethasone at 20mg/dose, q 6 hours * 3 doses at day 
#1 and day #2 in q 21day cycle for 12 cycles in maximum”. 
6. Study calendar (1)  “Chest X-ray will done at 6 day +/- 1, 12 day +/- 1, 18 day +/- 1, 
etc during the treatment period”. 
7. Study calendar (2)  CBC/Differential/Platelets test is scheduled on Weeks 4, 7 and 10 
during treatment period. 
8. Assessment schedule  “Clinical assessment will be done while On-study, q 4 month * 1 
yr, q 6 month * 2 yr, and q year after that”. 
Table 1. Temporal knowledge examples in clinical trial protocols. 
Handle temporal indeterminacy Although temporal 
constraints in clinical trial protocols are prescriptive 
and rigorously defined, they also allow for some 
flexibility. A knowledge representation for the tem-
poral specification of protocol events must include 
indeterminacy.
5 However, in order to enforce adher-
ence to the protocol, this indeterminacy must be 
specified precisely.  
There are several types of indeterminacy. First, the 
occurrence of an activity might allow for flexibility. 
For example, in Table 1, row 6, the patient’s visits 
have an indeterminacy expressed as “+/- 1 day”. We 
can capture this type of indeterminacy with concepts 
such as “expected occurrence”, and “earliest/latest 
occurrence”. Second, the duration of a temporal in-
terval in the protocol may be indeterminate. For ex-
ample, a treatment period may have an expected du-ration of 5 weeks, but may be delayed due to patient 
toxicities to become 6 weeks or more. Finally, an 
entire sequence of events may occur at an indetermi-
nate time. For example, protocols may have a sched-
ule of tasks (such as an exit interview, or final disease 
assessment) associated with protocol termination. 
These events may be triggered at an unknown time—
patients are always allowed to leave for any reason, 
or they may be forced to leave the protocol due to 
disease progression or toxic reactions. In spite of 
their indeterminacy, once such events are triggered 
(and an anchor point is established), the protocol may 
specify temporal constraints on a set of exit tasks.  
Represent cyclical event patterns It is necessary to 
represent cyclical event patterns simply because there 
are many recurrent temporal activities in clinical trial 
protocols. In Table 1, rows 5 and 8 are examples of 
explicit cyclical activities. Sometimes cyclical pat-
terns may be implicit. For example, row 7 of Table 1 
might be interpreted as a cyclical pattern of testing, 
namely, “every 3 weeks, starting with week #4 of 
treatment”. When generating patient-specific sched-
ules, a significant task is understanding and “unroll-
ing” these cyclical patterns. Therefore, representa-
tions for cyclical patterns should support efficient 
reasoning over such patterns. 
Represent both time points and time intervals In 
scheduling tasks for clinical trial protocols; there is 
usually a large gap between the temporal granular-
ities of an activity’s duration and the intervals be-
tween activities. Therefore, usually it is important to 
decide when a task happens, and it is not as important 
to know how long a task lasts. For example, a proto-
col might specify “Patients should have a physical 
examination every 2 weeks during the treatment pe-
riod”. The duration of the physical examination is 
brief compared to 2 weeks or the duration of the 
treatment period. Therefore, using time points to rep-
resent tasks or activities as instantaneous objects is 
appropriate and can simplify calculations. On the 
other hand, clinical studies are usually divided into 
different periods such as “pre-study”, “treatment pe-
riod” and “follow-up”. These longer intervals are 
used to define the duration of some activity patterns. 
Thus, it is also important to represent time intervals.  
A Temporal Ontology 
We have built an example of a temporal ontology that 
satisfies the above requirements and can be used to 
support scheduling tasks for clinical trial protocol 
applications. Our ontology includes the temporal 
concepts and distinctions necessary for time-related 
decision-support applications for clinical trial proto-
cols. Although we cannot know a priori what an arbi-
trary application might need, our model at least satis-
fies the requirements of prototype systems we have 
built to date. We constructed our ontology with the 
Protégé-2000 environment,
8 and in conjunction with 
a more general model for clinical trial protocols. Fig-
ure 1 shows the major classes in our temporal ontol-
ogy: time point, time interval, and event pattern.  
A time point is an instantaneous object, without dura-
tion. An absolute time point is associated with an 
absolute calendar date. We use two features, “an-
chored time point” and “offset from the anchor” to 
define relative time information for “Relative Time 
Point”. For example, for a treatment period of 6 
months, we would define “treatment start” as an ab-
solute time point, and then “treatment end” as a rela-
tive time point, anchored to “treatment start” with an 
offset of 6 months. (This time offset could be any of 
the three types shown in Figure 1.) 
A “Cyclical Time Point” is a special type of relative 
time point, with two additional features: repeat times 
and repeat interval. To represent “q 4 month * 1 yr” 
(as seen in Table 1, row 8), we can define a cyclical 
time point with a repeat interval of 4 months and a 























Time Interval Time Point 
Time Offset Time Objects 
Figure 1. Classes in our temporal ontology. There are 
three types of time objects, and a supporting class 
(time offset) that provides information about durations During  Radiation, 
Weekly 
Every 3 months after 
therapy (1
st 2 years) 
Every 6 months after 
therapy (next 3 years) 
CBC, Differential, Platelets  X  X  X 
Creatinine X  X  X 
Tumor Measurement    X  X 
Table 2. A portion of the study calendar for protocol GOG #160. 
We define three types of time intervals. The most 
common is a time interval bounded by two end 
points. However, for clinical trial protocols, we found 
it useful to also define a “one point time interval”, 
where we ignore one end of the interval due to uncer-
tainty. Examples of this type of time intervals include 
“pre-study”, where the end point is known, but not 
the start point, and “follow up”, where the end point 
may not be known, i.e. “until death” or “until disease 
progression”. The third type of time interval is a “cy-
clical time interval”, which is anchored to a cyclical 
time point and has a repeat duration.  
An Event Pattern defines patterns for temporal activi-
ties in clinical trials. There are two types of temporal 
event patterns: single and cyclical. These specify how 
temporal activities are anchored to time points and 
how often they will happen. We use cyclical event 
pattern together with cyclical time point to represent 
cycles such as those seen in Table 1. 
Scheduling Task Scenario: Study Calendaring 
Based on our temporal ontology, we built a prototype 
scheduling decision-support tool, which mainly 
makes use of the study calendar in clinical trial pro-
tocols to support patient visit scheduling. In paper 
clinical trial protocols, the study calendar is a 2-
dimensional table, where rows define different study 
tests and columns define time patterns or temporal 
constraints. As an example, Table 2 shows a small 
portion of the study calendar for the clinical trial pro-
tocol GOG #160.
9 When a patient enrolls in this pro-
tocol, the scheduling task is to generate a patient-
specific schedule of visits and clinical tasks.  
In our prototype system, we first need to encode or 
capture the temporal information about protocol 
events using our time entity model. Using the portion 
shown in Table 2 we would proceed as follows: 
1)  Define “therapy starts” and “therapy ends” as time 
points. “Therapy ends” can be an anchored time 
point referring to “therapy starts”, with an offset 
equal to the duration of the therapy.  
2)  Define three time patterns: “weekly cycle”, “every 
3 months” and “every 6 months”. The “weekly cy-
cle” pattern is anchored to the “therapy starts”; the 
other patterns are anchored to “therapy ends”. 
Their repeat times need to be computed. For exam-
ple, the repeat times for pattern #1 is equal to the 
number of weeks of treatment; whereas pattern #2 
repeats eight times, and pattern #3, six times.  
3) Associate clinical tasks with different time pat-
terns. “CBC, Differential, and Platelets” is associ-
ated with all three patterns; “Tumor Measurement” 
is associated just with patterns #2 and #3.  
To capture all temporal constraints, sometimes we 
need information beyond that specified in the calen-
dar: in this protocol, we need the duration of radia-
tion treatment (five weeks). After that, we will incor-
porate patient data such as enrollment time and ther-
apy ending time to assign time values to some "an-
chored time points". Then, we can reason over the 
temporal patterns and generate patient visits schedule 
showing when “CBC, differential, Platelets” should 
occur or when “tumor measurement” should happen.  
We have entered about a dozen protocols and proved 
our ability to generate hypothetical patient-specific 
schedules from these protocols. However, our aim is 
not to build a user-ready tool for scheduling, but 
rather to explore the usefulness of an expressive 
knowledge representation. In fact, we envision a set 
of additional capabilities that could be built on top of 
our knowledge model. For example:  
• How much do different time patterns overlap? Rea-
soning about overlapping activities could be impor-
tant for resource management. 
• On a particular date, which tests and tasks need to 
co-occur? This information is not usually explicit 
in the protocol document, and must be inferred. 
• How many total patient visits are required to com-
plete a protocol and how long will the whole study 
last (given some assumptions)?  
In sum, there are a number of scheduling-related 
temporal reasoning tasks. To help care providers with 
these tasks, we envision a series of decision-support 
tools that would benefit from our temporal ontology. Discussion 
In this paper, we summarize the temporal knowledge 
representation requirements for scheduling tasks in 
clinical trial protocols and propose an ontology that 
meets the temporal reasoning needs of scheduling 





contrast to these more interval-based efforts, we view 
"clinical tasks" from a scheduling perspective as in-
stantaneous events relative to the context when they 
happen. This view led us to define "temporal event 
patterns", which do not exist in EON or ASBRU, to 
capture temporal features of sets of clinical tasks. 
In addition, rather than requiring users to explicitly 
define interval relationships such as DO-ALL-
TOGETHER or DO-ALL-SEQUENTIAL such as are 
defined in ASBRU, we support the automatic reason-
ing of temporal relationships among time intervals. In 
this way, we find it is efficient to do temporal reason-
ing over clinical tasks' event patterns. 
Although EON supports temporal representation and 
abstraction of patterns in clinical patient data,
10 it 
does not address the scheduling requirements for 
temporal representation and reasoning over clinical 
events. Both EON and ASBRU are designed to repre-
sent clinical guidelines as well as protocols. For our 
purposes, this means that their models include fea-
tures and classes that are not necessary for protocols. 
For example, definitions of “intentions” or “prefer-
ences” for time intervals in ASBRU are not necessary 
for the scheduling task.  
We expect that our temporal representation of events 
will enable the development of a number of reason-
ing tools. For example, we could build a tool to 
automatically generate optimal patient visit schedules 
based on our representation of clinical tasks’ event 
patterns and their temporal indeterminacy. In particu-
lar, if all tasks specified by the protocol include a 
temporal window within which the task may be ac-
complished, then a system could compute an optimal 
set of visits so that all tasks are carried out while 
minimizing the number of distinct visits. Besides 
patient visits scheduling, we also propose possible 
applications such as “form submission scheduling”, 
“drug modification scheduling”, “risk assessment 
scheduling”, etc.  
Finally, we argue that an expressive temporal model 
specifically for clinical trial protocols could support a 
protocol-authoring tool by manipulating all sorts of 
complex temporal constructs. Such a tool might be 
able to detect potential problems as protocols are 
being written, such as incompleteness, ambiguity, or 
even inconsistent temporal information across differ-
ent sections of the protocol. In summary, we see 
many opportunities for future work and tool devel-
opment that could benefit from our temporal ontol-
ogy for clinical trial protocols.  
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